Monday, April 26, 2021

Avivagen Inc. (VIVXF)(VIV:CA)
Receives Largest Single Purchase Order

Avivagen Inc is a Canadian based company operating in the healthcare sector. It develops science-based, natural health products for animals. It develops and commercializes products for livestock feeds to replace antibiotics for growth promotion and to help prevent disease by supporting the animal’s own health defenses. Its product range includes OxC-beta, Vivamune health chews, Oximunol chewable tablets, and Carotenoid Oxidation products.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Order. On Friday, Avivagen announced it had received a purchase order for a single shipment of 4.4 metric tonnes of OxC-beta Livestock. This represents the largest single shipment purchase order of OxC-beta to date and represents a 10% increase in size over the previous record single shipment order. This one order represents more than 40% of the previous year’s total volume. The order continues the momentum seen by Avivagen in the acceptance of OxC-beta as an alternative to antibiotics in animal feed, in our view.


UNAHCO.  Friday’s order was placed by UNAHCO, one of the earliest adopters of OxC-beta. Since UNAHCO’s first order in November 2016 of 150 kilograms for use in swine feed, UNAHCO’s demand for the product has grown significantly. In April 2020, UNAHCO placed a three tonne order, which was 50% larger than any previous order, only to top that with a four tonne order In October of last year. Including …

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision.